skip to content

 

Dr James Thaventhiran joins Dr Nicholas Matheson for the CITIID's weekly COVID-19 update

21 April 2020

On the 16th April, Dr James Thaventhiran joined Dr Nicholas Matheson for the Cambridge Institute of Therapeutic Immunology and Infectious Disease's (CITIID) weekly COVID-19 update. This talk, along with all other previous updates from the CITIID, can be found here. Details of the weekly webinar can be found here . Each...

Read more

Thaventhiran lab's publication selected as one of the top ten papers of 2019 by the Journal of Experimental Medicine

19 March 2020

The Thaventhiran lab's paper 'Loss of the interleukin-6 receptor causes immunodeficiency, atopy, and abnormal inflammatory responses' has been selected as one of the Top Ten Papers of 2019 by the Journal of Experimental Medicine (JEM). Brief Definitive Report Interleukin-6 receptor deficiency Sarah Spencer; Sevgi Köstel...

Read more

New European Partnerships to Accelerate Cancer Research

19 March 2020

Cancer Research UK and its European partners, Fondazione AIRC and Asociación Española Contra el Cáncer (AECC), will invest £27.4 million into seven new international projects to accelerate lifesaving cancer research. The Cancer Research UK Accelerator Awards programme, which provides five years of funding for international...

Read more

Ritwick Sawarkar receives Alfred Tissières Young Investigator Award

13 March 2020

The MRC Toxicology Unit would like to congratulate Dr Ritwick Sawarkar who recieved The Alfred Tissières Young Investigator Award 2019. This award was established by The Executive Council of the Cell Stress Society International. Dr Sawarkar received the award for his contribution to the heat shock and cellular stress...

Read more

ESTIV Early Career Award granted to Dr. Timothy Allen

20 January 2020

The MRC Toxicology Unit is pleased to announce that Dr Timothy Allen has been granted the first European Society of Toxicology In Vitro (ESTIV) Early Career Award. More information about the ESTIV Early Career Award can be found here: https://www.estiv.org/estiv-early-career-award-granted-to-dr-timothy-allen/

Read more

Air pollution from brake dust may have same harmful effects on immune cells as diesel exhaust

20 January 2020

Metal particles from the abrasion of brake pads - up to a fifth of fine particulate matter (PM2.5) air pollution at roadsides - may cause inflammation and reduce the ability of immune cells to kill bacteria, a new study has found, similarly to particles derived from diesel exhaust. The scientists, primarily funded by the...

Read more

PhD Studentships Available

15 January 2020

The MRC Toxicology Unit is now advertising for four PhD Studenstships commencing in October 2020. The four projects are: Toxicity-induced phase separation of transcriptional regulators: mechanisms and cellular consequences - Supervisor: Dr Ritwick Sawarkar Single Cell assessment of adaptive immune clonal expansion and...

Read more

New exciting paper from the Willis Lab

18 December 2019

We are pleased to announce a new paper from the Willis lab, which made front cover of science signaling, shows the common chemotherapy doxorubicin can promote the migration of cancer cells through phosphorylation of a translation factor. Please see the links to the article published in Science Signaling below: Summary...

Read more

Welcome to our new group leaders

22 October 2019

The Unit is delighted to announce the appointment of three new group leaders: Mike Chapman, Ritwick Sawarkar and Kiran Patil. Mike Chapman Mike’s programme will focus on the toxicity of CAR-T cell therapy. The lab will be combining genomic and proteomic approaches with more traditional ‘wet lab’ techniques to dissect the...

Read more

Welcome to Dr Mathew Van de Pette

18 September 2019

The Unit is delighted to announce that Dr Mathew Van de Pette has joined on 1st September as Programme Leader Track. Mat's programme is aimed at understanding the mechanisms by which environmental stressors induce changes to epigentic pathways in utero.

Read more